Ripretinib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 September 2024

  • curprev 15:2315:23, 12 September 2024Alen Antony talk contribs 1,005 bytes +1,005 Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=ripretinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=Gastrointestinal stromal tumor in adults who have been already treated with # or more kinase inhibitors, including imatinib. |adverseReactions=alopecia, fatigue, nausea, abdominal pain, constipation, myalgia, diarrhea, decreased appetite, palmar-plantar erythrodysesthesia, and vomiting |offLabelAdultGuideSupport=The recommended..."